Trials / Completed
CompletedNCT03061825
Zenith Alpha™ Abdominal Endovascular Graft
Post-Market Study for Zenith Alpha™ Abdominal Endovascular Graft
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith Alpha™ Abdominal Endovascular Graft | Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm. |
Timeline
- Start date
- 2017-05-24
- Primary completion
- 2021-01-06
- Completion
- 2021-01-06
- First posted
- 2017-02-23
- Last updated
- 2021-01-15
Locations
5 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT03061825. Inclusion in this directory is not an endorsement.